Preclinical studies with glioblastoma brain organoid co-cultures show efficient 5-ALA photodynamic therapy

Pedrosa, Leire; Bedia, Carmen; Diao, Diouldé; Mosteiro, Alejandra; Ferrés, Abel; Stanzani, Elisabetta; Martínez-Soler, Fina; Tortosa, Avelina; Pineda, Estela; Aldecoa, Iban; Centellas, Marc; Muñoz-Tudurí, Marta; Sevilla, Ana; Sierra, Àngels; González Sánchez, José Juan

Preclinical studies with glioblastoma brain organoid co-cultures show efficient 5-ALA photodynamic therapy

Mostra el registre complet Registre parcial de l'ítem

dc.contributor.author Pedrosa, Leire
dc.contributor.author Bedia, Carmen
dc.contributor.author Diao, Diouldé
dc.contributor.author Mosteiro, Alejandra
dc.contributor.author Ferrés, Abel
dc.contributor.author Stanzani, Elisabetta
dc.contributor.author Martínez-Soler, Fina
dc.contributor.author Tortosa, Avelina
dc.contributor.author Pineda, Estela
dc.contributor.author Aldecoa, Iban
dc.contributor.author Centellas, Marc
dc.contributor.author Muñoz-Tudurí, Marta
dc.contributor.author Sevilla, Ana
dc.contributor.author Sierra, Àngels
dc.contributor.author González Sánchez, José Juan
dc.date.accessioned 2023-09-13T07:11:34Z
dc.date.available 2023-09-13T07:11:34Z
dc.date.issued 2023
dc.description.abstract Background: The high recurrence of glioblastoma (GB) that occurs adjacent to the resection cavity within two years of diagnosis urges an improvement of therapies oriented to GB local control. Photodynamic therapy (PDT) has been proposed to cleanse infiltrating tumor cells from parenchyma to ameliorate short long-term progression-free survival. We examined 5-aminolevulinic acid (5-ALA)-mediated PDT effects as therapeutical treatment and determined optimal conditions for PDT efficacy without causing phototoxic injury to the normal brain tissue. Methods: We used a platform of Glioma Initiation Cells (GICs) infiltrating cerebral organoids with two different glioblastoma cells, GIC7 and PG88. We measured GICs-5-ALA uptake and PDT/5-ALA activity in dose-response curves and the efficacy of the treatment by measuring proliferative activity and apoptosis. Results: 5-ALA (50 and 100 µg/mL) was applied, and the release of protoporphyrin IX (PpIX) fluorescence measures demonstrated that the emission of PpIX increases progressively until its stabilization at 24 h. Moreover, decreased proliferation and increased apoptosis corroborated the effect of 5-ALA/PDT on cancer cells without altering normal cells. Conclusions: We provide evidence about the effectiveness of PDT to treat high proliferative GB cells in a complex in vitro system, which combines normal and cancer cells and is a useful tool to standardize new strategic therapies.
dc.description.sponsorship This research was funded Laboratorios Gebro Pharma S.A. The authors also received support from the Spanish Ministry of Health and Consumer Affairs, the ISCIII-Subdirección General de Evaluación, AECC (Spanish Association Against Cancer. Project GCTRA16015SEDA) and the Fondo Europeo de Desarrollo Regional (FEDER) FIS-PI18/00916. A.S. was supported by the grant PGC 2018-098626-B-100 funded by MCIN/AEI/10.13039/501100011033 and by the ERDF A way of making Europe, the grant PDC 2022-133826-100 funded by MCIN/AEI/10.13039/501100011033 and by the European Union Next GenerationEU/PRTR and the Merck Salud Foundation grant RL001213. A.S. is a recipient of a Ramón y Cajal contract supported by the Grant (RYC-2016-19962) funded by MCIN/AEI/10.13039/501100011033 and by the “ESF investing in your future”. C.B. is a recipient of Grant CEX2018-000794-S funded by MCIN/AEI/10.13039/501100011033.
dc.format.mimetype application/pdf
dc.identifier.citation Pedrosa L, Bedia C, Diao D, Mosteiro A, Ferrés A, Stanzani E, Martínez-Soler F, Tortosa A, Pineda E, Aldecoa I, Centellas M, Muñoz-Tudurí M, Sevilla A, Sierra À, González Sánchez JJ. Preclinical studies with glioblastoma brain organoid co-cultures show efficient 5-ALA photodynamic therapy. Cells. 2023;12(8):1125. DOI: 10.3390/cells12081125
dc.identifier.doi http://dx.doi.org/10.3390/cells12081125
dc.identifier.issn 2073-4409
dc.identifier.uri http://hdl.handle.net/10230/57853
dc.language.iso eng
dc.publisher MDPI
dc.relation.ispartof Cells. 2023;12(8):1125
dc.relation.projectID info:eu-repo/grantAgreement/ES/2PE/PGC2018-098626-B-100
dc.relation.projectID info:eu-repo/grantAgreement/ES/3PE/PDC2022-133826-100
dc.relation.projectID info:eu-repo/grantAgreement/ES/1PE/RYC-2016-19962
dc.relation.projectID info:eu-repo/grantAgreement/ES/2PE/CEX2018-000794-S
dc.rights © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.subject.keyword 3D tumor models
dc.subject.keyword 5-ALA
dc.subject.keyword Drug screening
dc.subject.keyword Glioblastoma
dc.subject.keyword Neurological cancers
dc.subject.keyword Organoids
dc.subject.keyword Personalized medicine
dc.subject.keyword Photodynamic therapy
dc.subject.keyword Spheroids
dc.title Preclinical studies with glioblastoma brain organoid co-cultures show efficient 5-ALA photodynamic therapy
dc.type info:eu-repo/semantics/article
dc.type.version info:eu-repo/semantics/publishedVersion

Col·leccions

Articles (Departament de Medicina i Ciències de la Vida)